- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01187082
Grouptraining for Overactive Bladder in Adults
A Clinical, Randomized, Comparative, Non-blinded Study on the Effect of Bladdertraining in Groups Compared to Individual Bladdertraining for Female Patients With Overactive Bladder.
Hypothesis:the effect of bladdertraining in groups for patients with OAB (overactive bladder syndrome) equals the effect of bladdertraining individually for patients with overactive bladder.
The effect of the training is measured in a 3 dimensional scope by the means of 3 primary outcome measures used in the statistical evaluation. Symptoms of OAB (either (1)urgencyepisodes or (2)urgencyincontinence) and (3)quality of life (VAS score).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Glostrup, Denmark, 2600
- Glostrup Hospital
-
Kolding, Denmark, 6000
- Kolding Sygehus, urogynecology department
-
Sønderborg, Denmark, 6400
- Sønderborg Sygehus, Gynækologiske Ambulatorium
-
Viborg, Denmark, 8800
- Regionshospitalet Viborg, Kontinensklinikken
-
Århus, Denmark, 8300
- Århus Universitetshospital, Skejby, urogynaekology dep.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- women at the age of 18 and more
- patients with overactive bladder
Exclusion Criteria:
- dominance of stress incontinence
- not able to attend sessions
- do not to understand danish
- do not want training in groups or individual
- hormonebalanced (if postmenopausal with added hormonetreatment for at least 2 months)
- no treatment for OAB up till 1 month before study and during study
- no renal or neurological diseases, symptomatic cystitis or non regulated diabetes
- no pregnancy during study
- no normal gynecological examination
- no operation in pelvis up till 3 month before studystart
- no polyuria measured 2 times before studystart (> 40 ml/ kg/ day)
- no upstart of treatment with medication during studystart which according to the investigator can create symptoms of OAB
- no participation in other CT
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: bladdertraining group
Cognitive training in groups at hospital by a continence nurse in 3 sessions (1 hour)over a period of 1 month.
Follow up after 1 month.
During all 2 month the patient has selfinitiatied daily training with a pocket bladder schedule.
|
Cognitive training in groups of 4 patients at hospital by a continence nurse in 3 sessions (1 hour)over a period of 1 month.
Follow up after 1 month.
During all 2 month the patient has selfinitiatied daily training with a pocket bladder schedule.
|
|
Active Comparator: bladdertraining individually
Cognitive training individually at hospital by a continence nurse in 3 sessions (1 hour)over a period of 1 month.
Follow up after 1 month.
During all 2 month the patient has selfinitiatied daily training with a pocket bladder schedule.
|
Cognitive training individually at hospital by a continence nurse in 3 sessions (1 hour)over a period of 1 month.
Follow up after 1 month.
During all 2 month the patient has selfinitiatied daily training with a pocket bladder schedule.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
urgencyepisodes
Time Frame: after 2 month (end of study)
|
with a bladderdiary episodes are counted at studystart / after 3 sessions of training and after 2 month (studyend)
|
after 2 month (end of study)
|
|
urgeincontinence
Time Frame: after 2 month (studyend)
|
with a bladderdiary episodes are counted at studystart / after 3 sessions of training and after 2 month (studyend)
|
after 2 month (studyend)
|
|
VAS score from ICI_OAB_Q
Time Frame: after 2 month (studyend)
|
with the ICI_OAB_Q counted before studystart / after 3 sessions/ after 2 month (studyend)
|
after 2 month (studyend)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
voiding frequency
Time Frame: after 2 month (studyend)
|
counted from a bladder diary before studystart/ after 3 sessions of training/ after 2 month (studyend)
|
after 2 month (studyend)
|
|
Compliance in training
Time Frame: after 2 month (studyend)
|
counted from a pocket bladder schedule at every training session (3 times)and after 2 month (studyend)
|
after 2 month (studyend)
|
|
Adverse events
Time Frame: after 2 month (studyend)
|
asked at every training session (3 times)and after 2 month (studyend).
Patients are supposed to report in if any AEs during study
|
after 2 month (studyend)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kirsten Kaysen, nurse, Arhus Universitetshospital, Skejby
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BLATRA 01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overactive Bladder
-
Ankara Yildirim Beyazıt UniversityCompletedOveractive Bladder | Overactive Detrusor | Overactive Bladder SyndromeTurkey
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedOveractive Bladder (OAB)United States, Canada, Germany, Korea, Republic of, Spain, Turkey, Taiwan, Italy, Slovakia, Denmark, South Africa, United Kingdom, Mexico, Sweden, Norway
-
Medstar Health Research InstituteColumbia University; University of Michigan; University of New Mexico; Methodist...Terminated
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Merck Sharp & Dohme LLCTerminatedOveractive Bladder | Overactive Urinary Bladder
-
Loyola UniversityAstellas Pharma IncCompletedOveractive Bladder SyndromeUnited States
-
Beijing Pins Medical Co., LtdUnknown
-
Maastricht University Medical CenterUnknownLower Urinary Tract Symptoms | Overactive Bladder SyndromeNetherlands
-
Pamukkale UniversityCompletedElectrical Stimulation | Idiopathic Overactive Bladder | Bladder TrainingTurkey
Clinical Trials on bladdertraining in groups
-
Mental Health Services in the Capital Region, DenmarkCompleted
-
Karolinska University HospitalCompleted
-
Fundacion para la Formacion e Investigacion Sanitarias...UnknownChildhood Obesity PreventionSpain
-
University Hospital of North NorwayThe Royal Norwegian Ministry of Health; Finnmark Hospital Trust; Norwegian Foundation... and other collaboratorsCompleted
-
Ain Shams UniversityNot yet recruitingMaternal Obesity | Hypoxia Neonatal
-
City, University of LondonThe Stroke Association, United KingdomCompleted
-
University of BergenUniversity of AgderCompleted
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); M...Completed
-
Ondokuz Mayıs UniversityCompletedPeriodontal Diseases